Erythropoietin attenuates pulmonary vascular remodeling in experimental pulmonary arterial hypertension through interplay between endothelial progenitor cells and heme-oxygenase
BackgroundPulmonary arterial hypertension (PAH) is a pulmonary vascular disease with a high mortality, characterized by typical angio-proliferative lesions. Erythropoietin (EPO) attenuates pulmonary vascular remodeling in PAH. We postulated that EPO acts through mobilization of endothelial progenito...
Saved in:
Main Authors: | Rosa L.E. Loon (Author), Beatrijs eBartelds (Author), Frank A.D.T.G. Wagener (Author), Nada eAffara (Author), Saffloer eMohaupt (Author), Hans eWijnberg (Author), Sebastiaan W.C. Pennings (Author), Janny eTakens (Author), Rolf M.F. Berger (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2015-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Pulmonary Artery Pulsatility Index Provides No Additional Prognostic Information in Pediatric Pulmonary Arterial Hypertension
by: Faye E. Smits, et al.
Published: (2024) -
Pediatric pulmonary hypertension
by: Maurice eBeghetti, et al.
Published: (2015) -
Therapeutic strategies in pulmonary hypertension
by: Leonello eFuso, et al.
Published: (2011) -
Echocardiography in pediatric pulmonary hypertension
by: Pei-Ni eJone, et al.
Published: (2014) -
Pulmonary Manifestations of Primary Immunodeficiency Disorders in Children
by: Milos eJesenak, et al.
Published: (2014)